Literature DB >> 11892540

Pathogenesis and treatment of rhabdomyolysis.

Stacy A Rupert1.   

Abstract

PURPOSE: To provide clinicians in primary and acute care settings with information on the evaluation, diagnosis, and treatment of rhabdomyolysis. DATA SOURCES: Selected review articles from print and electronic sources, and a case study.
CONCLUSIONS: Rhabdomyolysis is a common disorder, which may result from a large variety of diseases, trauma, or toxic insults to skeletal muscle. It is caused by skeletal muscle injury and results in the release of muscle contents (i.e., myoglobin) into the plasma. Muscular, urinary, and general internal disturbances are the three areas where signs and symptoms occur. IMPLICATIONS FOR PRACTICE: Clinical signs and symptoms vary widely. Associated life-threatening complications include acute renal failure, cardiac arrhythmias and arrest, disseminated intravascular coagulation, and compartment syndrome. Early recognition and treatment in the acute phase of rhabdomyolysis are keys to successful outcomes and an excellent recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11892540     DOI: 10.1111/j.1745-7599.2002.tb00095.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  3 in total

1.  Rhabdomyolysis: a case study exploring the possible side effect of lipid lowering medication by a HIV positive patient taking a protease inhibitor.

Authors:  Diana De Carvalho; Mark Citro; Anthony Tibbles
Journal:  J Can Chiropr Assoc       Date:  2008-12

2.  Rhabdomyolysis in 114 patients with acute poisonings.

Authors:  Seyed Reza Mousavi; Maryam Vahabzadeh; Adeleh Mahdizadeh; Mansooreh Vafaee; Mahmood Sadeghi; Reza Afshari; Mahdi Balali-Mood
Journal:  J Res Med Sci       Date:  2015-03       Impact factor: 1.852

3.  Successful Treatment of Hypokalemic Rhabdomyolysis Caused by a Pancreatic VIPoma: A Case Report.

Authors:  Sergio Ramirez; Meghan Lytle; Enrique Togores; Jorge Parellada; Steve J Carlan; Mario Madruga; Rodrigo M Murillo-Alvarez
Journal:  Am J Case Rep       Date:  2019-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.